Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study-Reference-Cited by-同舟云学术

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

Published:2015-06-01 Issue:1 Volume:7 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Dumurgier Julien,Schraen Susanna,Gabelle Audrey,Vercruysse Olivier,Bombois Stéphanie,Laplanche Jean-Louis,Peoc’h Katell,Sablonnière Bernard,Kastanenka Ksenia V,Delaby Constance,Pasquier Florence,Touchon Jacques,Hugon Jacques,Paquet Claire,Lehmann Sylvain

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1186/s13195-015-0114-5.pdf

Reference28 articles.

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63–75.e2.

2. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.

3. Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010. J Neuropathol Exp Neurol. 2012;71:266–73.

4. Mouton-Liger F, Wallon D, Troussière AC, Yatimi R, Dumurgier J, Magnin E, et al. Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study. J Neurol. 2014;261:144–51.

5. Rosén C, Hansson O, Blennow K, Zetterberg H. Fluid biomarkers in Alzheimer’s disease - current concepts. Mol Neurodegener. 2013;8:20.

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSEN2 Mutations May Mimic Frontotemporal Dementia: Two New Case Reports and a Review;Biomedicines;2024-08-17

2. Exploring the parity paradox: Differential effects on neuroplasticity and inflammation by APOEe4 genotype at middle age;Brain, Behavior, and Immunity;2024-08

3. TDP-43 Promotes Amyloid-Beta Toxicity by Delaying Fibril Maturation via Direct Molecular Interaction;ACS Chemical Neuroscience;2024-07-29

4. Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer’s Disease;International Journal of Molecular Sciences;2024-05-25

5. Alzheimer’s disease and its treatment–yesterday, today, and tomorrow;Frontiers in Pharmacology;2024-05-24